Category Archives: Molecular Medicine

Integrative Molecular Medicine (IMM) Online ISSN: 2056-6360 University College London Cancer Treatment Centers of America

Integrative Molecular Medicine (IMM) is a peer-reviewed, online open access journal dedicated to a new research discipline at the interface between clinical research and basic biology. We aim to publish articles that broadly enlighten the biomedicine research community by providing an insight on breakthrough discoveries in basic and clinical medicinal research, thereby lending a strong impetus to this important and rapidly developing field and helping to forge new links between clinicians and molecular biologists. Integrative Molecular Medicine highlights ongoing integrative basic and clinical biomedicines covering fields of biology and medicine.As such the following qualities are essential in any article published by the journal: scientific credibility and rigour, and coherence and clarity in the writing. Contributions do not need to be novel as confirmatory and replication studies will be considered, however the article must present new findings, which could include the reporting of negative findings.

IMM provides a new platform for all researchers, scientists, scholars, students to publish their research work and update the latest research information.Integrative Molecular Medicine publishes research articles as full-length research papers and short reports. In addition, the journal publishes editorials and review articles in innovative formats that target a broad and non-specialized audience.

Journal will accept article from the following topics are integrative medical fields including biochemistry, molecular and cell biology, biotechnology, genetics, physiology, endocrinology, signal transduction, cell proliferation, differentiation and development, stem cells and regenerative medicine apoptosis, gene expression, pathology, metabolic disease, genomics, transcriptomics, proteomics, metabolomics of disease, systems medicine, brain disease, cardiovascular biology, diabetes, obesity, osteoporosis, nutrition, pharmacology, toxicology, cancer biology and oncology, epidemiology, genetic medicine, and other medicine-related topics.

IMM welcomes direct submissions of manuscripts from authors. You can submit your manuscript to: submissions@oatext.com; alternatively to: yamaguchi@oatext.com

I graduated as an MD at Lviv State Medical University (Ukraine) in 1983 with a great passion to become a surgeon in oncology. Thinking that a PhD in experimental oncology would help to realize my dream, I obtained my doctorate at the Institute of Experimental Oncology, National Academy of Sciences of Ukraine in 1987. A fellowship from the International Agency for Research on Cancer (IARC) took me even further from clinical oncology and also from Ukraine. I arrived in London on the first wave of perestroika and began my post-doctoral training in Jim Woodgett's laboratory at the Ludwig Institute for Cancer Research (UCL Branch). Subsequently, I worked in Mike Waterfield's laboratory at the same Institute studying signal transduction via the PI3 kinase pathway. In 1996, I started my own group at the Ludwig Institute for Cancer Research, focusing on the regulation of growth via the S6 kinase pathway. Since 2003, I have been a Professor in the Department of Biochemistry at UCL now renamed Structural and Molecular Biology, where I have an active research group working on signal transduction and cellular metabolism in health and disease. I have a strong research (113 papers in peer-reviewed journals, H-Index 52) and patent (10 world-wide patents) portfolio and run two drug discovery programs aimed at developing small molecule inhibitors, targeting ribosomal S6 kinase and Aurora A kinase.

Dr. Alvarez, a native of Argentina, joined CTCA in October 2014 to lead the companys global focus on cancer research. He is internationally known for his contribution to breast cancer multidisciplinary management, inflammatory breast cancer, and discovery and monitoring of minimal residual disease in solid tumors. As a medical oncologist, he has focused his clinical career the past two decades on treating patients with the most difficult cases of breast cancer. Prior to joining CTCA, Dr. Alvarez served for five years as an Assistant Professor in the University of Texas MD Anderson Cancer Center Department of Breast Medical Oncology, Division of Cancer Medicine in Houston, Tx. He also served as Assistant Professor at The Morgan Welch Inflammatory Breast Cancer Research Program. His additional experience includes teaching at the Department of Pathology and the Department of Internal Medicine, Universidad Nacional de La Plata, Argentina. He served as Chief, Oncology Section, Hospital Ramon Carrillo - San Carlos de Bariloche, Rio Negro, Argentina, and Instructor, Oncology Consultants P.A., Houston, Tx. He was Secretary of Clinical Oncology Section, School of Oncology, Fundacion Jose Maria Mainetti, Centro Oncologico de Excelencia, Gonnet, Argentina; and Member, Centro Oncologico de Excelencia, Gonnet.

Dr. Alvarez received his medical degree from Universidad Nacional de La Plata - Facultad de Medicina, Argentina. He completed his residency in internal medicine and medical oncology at Centro Oncologico de Excelencia - Gonnet, Argentina. Following completion of his medical oncology training, he pursued additional training in Clinical Pathology to further study molecular diagnostic and serve as Instructor at the Pathology Department with Dr. Pedro Laguens at the Universidad Nacional de La Plata. He also participated in multiple research activities and attended multiple grand rounds with Professors Jose Maria Mainetti and Alberto Luchina, and with several others became leaders in Argentinean oncology. Following his training in Argentina, he moved to Houston to pursue a medical residency in internal medicine at The University of Texas at Houston, and completed a fellowship in hematology and oncology at The University of Texas MD Anderson Cancer Center, Houston, TX. He earned a masters degree in cancer biology from the Graduate School of Biomedical Sciences at Houston. Dr. Alvarez has received numerous professional awards for his work in cancer research, including T-32 NIH CA009666 in 2006, Award of Excellence in Cancer Research by Texas Medical Society of Oncology in 2008, and the Susan Papizan Dolan Fellowship in Breast Cancer Research in 2008. He has participated in nearly $5 million in research grants and contracts with multiple clinical studies, including several Phase II Investigator Initiated Studies, since 2009 alone.

In 2014, he was Principal Investigator in a study related to monitoring minimal residual disease in locally advanced breast cancer and inflammatory breast cancer by detecting circulating tumor cells. The goal of this study, funded by Sister Institution Fund Network as part of the Global Academy Program Department at MD Anderson, is to identify molecular markers of breast cancer tumor recurrence. This clinical trial is currently active in the U.S., as well as in five academic Institutions across the world, including: INCan in Mexico, INEM in Peru, Clnica Alemana in Santiago de Chile, Barretos Hosptial in Brasil, and University of Oslo in Norway. Dr. Alvarez has authored more than 50 articles, abstracts and book chapters and is a frequent presenter at international oncology conferences. His professional memberships include: American Society of Clinical Oncology (ASCO,) American College of Physicians (ACP), American Society of Hematology (ASH), American Association of Cancer Research (AACR), and the Society of Clinical Research Associates (SOCRA). He was a founding member of Grupo de Estudio Tratamiento e Investigacion del Cancer del Sur (GETICS) in Argentina in 1996.

Hiromichi Nakadate Evrim Kurtoglu Shota Shirasaki Shigeru Aomura

Research Article-Integrative Molecular Medicine (IMM)

August 06, 2016

Taishi Koganemaru Koji Hori Misa Hosoi Kimiko Konishi Mitsugu Hachisu Hiroi Tomioka Masayuki Tani Yuka Kitajima Atsuko Inamoto

Case Report-Integrative Molecular Medicine (IMM)

August 09, 2016

Margaret Simonian

Editorial-Integrative Molecular Medicine (IMM)

August 09, 2016

Koji Wakame Akifumi Nakata Keisuke Sato Takehito Miura Anil.D.Kulkarni Marie-Francoise Doursout Alamelu Sundersan Ken-Ich Komatsu

Research Article-Integrative Molecular Medicine (IMM)

August 10, 2016

Veronica J. James Mark McGovern Peihong Wu Boyang Chang Yankeng Wu

Mini Review-Integrative Molecular Medicine (IMM)

August 18, 2016

Josh Hiller Celeste Vallejo Leo Betthauser James Keesling

Research Article-Integrative Molecular Medicine (IMM)

August 19, 2016

Gregory Lee

Research Article-Integrative Molecular Medicine (IMM)

August 25, 2016

Yoko Takai Asuka Matsuo Zhiwei Qiao Tadashi Kondo

Research Article-Integrative Molecular Medicine (IMM)

August 26, 2016

Oxenkrug G Cornicelli J van der Hart M Roeser J Summergrad P

Research Article-Integrative Molecular Medicine (IMM)

August 29, 2016

Cristina Daneri-Becerra Mario D. Galigniana

Research Article-Integrative Molecular Medicine (IMM)

August 22, 2016

Nepton Sheik Khoni GhazalehShoja E Razavi Himakshi Sharma

Research Article-Integrative Molecular Medicine (IMM)

August 22, 2016

Charles J. Malemud

Research Article-Integrative Molecular Medicine (IMM)

September 05, 2016

Nepton Sheik Khoni Abdul Rahman El Kinge Abdul Rahman El Kinge

Perspective-Integrative Molecular Medicine (IMM)

August 30, 2016

Akio Sugitachi Naoko Takahashi Yoshimori Takamori

Research Article-Integrative Molecular Medicine (IMM)

May 12, 2016

Alexander P Lykov Elena P Trifonova Olga V Sazonova Elena V Zonova

Research Article-Integrative Molecular Medicine (IMM)

May 14, 2016

Shigeru Aomura Hiromichi Nakadate Yuma Kaneko Akiyoshi Nishimura Remy Willinger

Research Article-Integrative Molecular Medicine (IMM)

May 18, 2016

Mitsumi Arito Hiroyuki Mitsui Manae S Kurokawa Kazuo Yudoh Toshikazu Kamada Hisateru Niki Tomohiro Kato

Research Article-Integrative Molecular Medicine (IMM)

May 26, 2016

Zen Kouchi

Research Article-Integrative Molecular Medicine (IMM)

May 27, 2016

Yoshimitsu Kiriyama Kunihiko Kasai Katsuhito Kino Hiromi Nochi

Research Article-Integrative Molecular Medicine (IMM)

June 10, 2016

Hisako Nakagawa Tadaaki Miyazaki

Research Article-Integrative Molecular Medicine (IMM)

June 13, 2016

Yoshikazu Hirasawa Hisayo Yokoyama Nooshin Naghavi Yoshihiro Yamashina Ryosuke Takeda Akemi Ota Daiki Imai Tomoaki Morioka Masanori Emoto Kazunobu Okazaki

Research Article-Integrative Molecular Medicine (IMM)

June 17, 2016

Toshihisa Ishikawa Masaharu Shinkai Takeshi Kaneko

Mini Review-Integrative Molecular Medicine (IMM)

June 22, 2016

Osman A Hamour Eman M.Fallatah Rawan O. Alshehri Zain A. Alshareef Halah F.AL-Enizi

Research Article-Integrative Molecular Medicine (IMM)

June 23, 2016

Kazuyuki Matsushima Mika Suematsu Chie Mifude Kuniyoshi Kaseda

Research Article-Integrative Molecular Medicine (IMM)

June 24, 2016

A. Espinosa-Jeffrey R. A. Arrazola B. Chu A. Taniguchi S. M. Barajas P. Bokhoor J. Garcia A. Feria-Velasco J. de Vellis

Research Article-Integrative Molecular Medicine (IMM)

June 25, 2016

Edna Aurelus

Research Article-Integrative Molecular Medicine (IMM)

July 07, 2016

Estela S. Estap

Commentary-Integrative Molecular Medicine (IMM)

July 07, 2016

Ricardo H. Alvarez Cancer Treatment Centers of America

Submission date: November 30, 2016 Publication date: January 31, 2017

Editor Affiliation: David W. Moskowitz MD FACP, Founder and CEO, GenoMed, Inc. (www.genomed.com)

Submission date: June 30, 2016 Publication date: August 03, 2016

Description of the Special Issue: It's widely agreed that molecular medicine will revolutionize the practice of medicine. Few people realize that it's long overdue. Linus Pauling and colleagues published "Sickle Cell Anemia, a Molecular Disease," in the November 1949 issue of Science, but the treatment for sickle cell disease remains unsatisfactory over 65 years later.

What has been holding up the medical revolution? Papers are solicited on this general topic. They may address any of the following topics, or another that the author feels is equally important:

1. Problems solving polygenic diseases 2. Is there a better approach to oncology? 3. Drug discovery and development in the 21st century 4. Shifting the healthcare industry to prevention: economic and legal challenges 5. The role of public health authorities 6. The role of the media 7. The role of investors

View original post here:
Molecular Medicine | Molecular Medicine Reports ...

The Department of Biochemistry and Molecular Biology is an integral part of the LSU Health in New Orleans, which includes the Schools of Allied Health, Dentistry, Graduate Studies, Medicine, and Nursing. The faculty within the Department have strong, diverse research interests including cancer molecular and cellular biology, neuropeptide and enzyme processing, protein biochemistry, gene promoter and expression analyses, molecular biology of aging, cardiac development, cancer genetics, and molecular epidemiology of cancer. The Department offers PhD and MD/PhD degrees. Students, postdoctoral research scientists, research faculty, and visiting faculty members make significant contributions to the Department's activities. Strong collaborations exist with Basic Science and Clinical researchers within the LSUHealth community, with research groups elsewhere on a national and international level, and with established and emerging biotechnology industry.

The Department is well-equipped with most modern biochemical equipment required for the analysis of nucleic acids and proteins, including a state-of-the-art microarray core, a DNA sequencing core, and preparative ultracentrifuges. The Department is also equipped with facilities for high-pressure liquid chromatography, fast protein liquid chromatography, fluorescent in situ hybridization, fluorescent activated cell sorting, and microinjection. The Health Sciences Center Core Laboratories contain facilities for oligonucleotide synthesis, peptide synthesis and microsequencing, mass spectroscopy, a fluorescence-activated cell sorter, and a phosphorimager. An Image Analysis facility includes a confocal microscope as well as a molecular modeling workstation.

The shop facilities of the Department contain all of the equipment needed for fabrication and repair of scientific equipment.

Together with the Neuroscience Center, the Department administers an extensive tissue culture facility, which provides sterile media preparation, long-term storage of cell lines in liquid nitrogen, and propagates cell lines. More than 100 cell lines are contained within the tissue culture liquid nitrogen banks.

In addition to its on-site library facilities, the Health Sciences Center belongs to a library consortium which provides inter-library loans of books and journals.

Sincerely, Arthur L. Haas, PhD Professor and Chairman

Continued here:
LSUHSC School of Medicine - Biochemistry and Molecular Biology

"One thing that was really great about the program was the combination of theory in the morning and practical work in the afternoon. This helped me keep everything in perspective and I found it highly motivating. In the lab I also learned so much; not only a lot of new techniques, but also how to approach and tackle a scientific question, and how to go about designing an experiment to specifically answer the question. Of course I had some idea about this before I began the program, but the lab placements enabled me to really practice this at a professional level. In my thesis right now, for example, I have a great deal of flexibility over the work Im doing, but I also have the chance to consistently check back with my supervisor to discuss next steps and possible future experiments. This combination of working independently but with support is essential for me to mature on the scientific level. In all, it also gives me the feeling that I am a researcher and not just another student."

Radwa Sharaf, graduate 2013, pursuing her PhD at Harvard soon.

Click here to find more about the International Master Program Molecular Medicine

Read the original post:
International Masters Program Molecular Medicine ...

The Graduate Training Program in Cellular and Molecular Medicine prepares scientists for laboratory research at the cellular and molecular level with a direct impact on the understanding, diagnosis, treatment and prevention of human diseases. The Ph.D. graduates of the Program will have a rigorous training in scientific research and a thorough knowledge of human biology and human diseases.

The CMM program grew out of a need for training at the interface between medicine and the traditional basic science disciplines. Rapid progress in cellular and molecular biology has strongly impacted clinical medicine, offering insights on fundamental causes of many diseases. Now new discoveries in the laboratory can be applied rapidly to the diagnosis, treatment and prevention of disease. This has been made possible by emerging technology that allows scientists to identify genetic and molecular defects causing or predisposing to disease. The trainees in this program are working precisely at this interface between science and medicine where they will be able to contribute to the long term well being of society.

Johns Hopkins University School of Medicine supports state of the art research and animal facilities, all on the East Baltimore campus.

Read more here:
Cellular and Molecular Medicine Graduate Program

From its home within the Department of Internal Medicine Section on Molecular Medicine, the Molecular Medicine and Translational Science program trains PhD students in research to better understand human diseases at a molecular level and translate that knowledge to improved diagnostics, treatment, and disease prevention. The MMTS program includes scientists from all major basic science and clinical programs at Wake Forest University and was one of the first established molecular medicine programs nationwide. Beginning in 2011, MMTS joined four other complementary PhD programs in the Wake Forest University Graduate Schools Molecular and Cellular Biosciences track, where combined expertise will be utilized to enhance the depth of student learning and discovery.

To learn more about the MMTS degree programs and their requirements, or aboutthe program's accomplished faculty, please follow the links on the left.

Program Directors and Contacts

Director: John S. Parks, PhD,Professor Department of Internal Medicine Molecular Medicine Phone: 336-716-2145 Email:jparks@wakehealth.edu

Co-Director: Robert N. Taylor, MD, PhD, Professor Department of Obstetrics and Gynecology Phone: 336-716-5451 Email: rtaylor@wakehealth.edu

Program Recruiter: Michael C. Seeds, PhD, Assistant Professor Department of Internal Medicine - Molecular Medicine Phone: 336-713-4259 E-mail: mseeds@wakehealth.edu

MMTS Policies and Procedures

MMTS Graduate Program Faculty

Molecular Medicine Journal Club

More here:
Molecular Medicine - Wake Forest Baptist Health

The mission of the MRC Weatherall Institute of Molecular Medicine (WIMM) is to undertake internationally competitive research into the processes underlying normal cell and molecular biology and to determine the mechanisms by which these processes are perturbed in inherited and acquired human diseases. It is also our mission to translate this research to improve human health. The WIMM is uniquely placed among biomedical institutes throughout the world in its pioneering vision of combining outstanding clinical research with excellent basic science. The WIMM Faculty currently includes an equal mixture of scientists and clinicians working together and in collaboration with the National Institute of Health Research, the NHS and commercial companies with the aim of improving the diagnosis and treatment of human diseases. The major topics of current research include haematology, immunology, stem cell biology, oncology and inherited human genetic diseases. The Institute benefits from strategic support from the MRC.

The Institute values communication with members of the broader scientific community and the general public and with the support of the Medical Research Council (MRC) we have commissioned three short videos to explain our mission.

This month, Dr Iztok Urbani joined Christian Eggeling's lab in the MRC Human Immunology Unit, supported by a prestigious Marie Skodowska-Curie postdoctoral fellowship. Iztok completed his studies in physics in 2009 at the University of Ljubljana, Slovenia, and obtained his PhD in biophysics in 2013 from the University of Maribor, Slovenia. During his 2-year fellowship here at the MRC WIMM, he will work on further improving super-resolution ...

The Lister Institute was founded in 1891 as a research institute researching vaccines and antitoxins, and over its impressive 125-year history has developed into one of the most prestigious funders of scientific research in the UK. Scientists supported by the Lister Institute have been involved in some of the most pivotal scientific and medical discoveries over the past century, including development of the UKs first diphtheria vaccine, ...

News Archive

We are seeking to appoint a Junior Group Leader in Computational Biology and Bioinformatics within the Human Immunology Unit (HIU), Investigative Medicine at the Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford (www.imm.ox.ac.uk/mrc-human-immunology-unit). Reporting to the Director of the HIU you will be required to add value to the ongoing programmes within the Unit as well as establish your own programme as Junior ...

Other Vacancies

Seeing is believing: what does your DNA look like in3D?

Clue: its a bit more complicated than a bendy ladder. Over the past year, scientists working in the Computational Biology Research Group and the MRC Molecular Haematology Unit at the MRC WIMM have been collaborating with Goldsmiths University in London to produce CSynth: new interactive software which allows users to visualize DNA structures in three dimensions. The team took the technology to New Scientist Live in September this year, and wowed hundreds of people with this incredible new tool. In this blog post, Bryony Graham describes the science behind the technology, and how the team managed to explain some pretty complex genomics to thousands of people using some pieces of string, a few fluffy blood cells and a couple of touchscreens, all whilst working under a giant inflatable E. coli suspended from the ceiling. Of course.

WIMM Blog Archive

Read the rest here:
Home - Weatherall Institute of Molecular Medicine

How signals are transmitted from receptors to biological effectors

How does the cell maintain a redox environment in the ER appropriate for oxidative protein folding

We study the excitatory glutamate activated receptor-channels in the vertebrate central nervous system

How Ras-related GTPases regulate basic cellular processes

To understand the biology and enzymology of protein palmitoylation

How bacterial signaling is controlling biofilm formation and pathogenicity

To understand the molecular and cellular events that direct the formation of vertebrate organs

We study the structure and function of nicotinic acetylcholine and glutamate receptors in signal transduction

To reveal the architecture and molecular mechanisms of membrane proteins that mediate extracellular signaling

The mission of the Department of Molecular Medicine is to make fundamental discoveries in basic research that will be relevant to and impact the biomedical community; educate and train graduate students, postdoctoral (Ph.D.) and DVM fellows, and educate veterinary students in the basic biological concepts that underlie the development of treatment strategies.

The over-arching theme of the research being conducted in Molecular Medicine is to obtain basic understandings of protein structure and function, protein-protein, and protein-membrane interactions as they pertain to fundamental processes in cell and developmental biology. The research efforts of the department faculty encompass cancer cell signaling and metabolism, structural determinations of membrane proteins and signaling systems, the molecular basis by which cells and their organelles respond to extracellular stimuli and stress, and signaling events that underlie neuronal transmission and function.

Continued here:
Department of Molecular Medicine - College of Veterinary ...

The Department of Molecular Medicine in the Institute of Biotechnology (IBT) was established in 1994 to administer a program to train graduate students at the interface of basic and clinical sciences with an emphasis on biomedical research focused on discovering the molecular mechanisms underlying human disease and to serve as a platform for the development of novel treatment or prevention approaches. To date, our program has awarded over 80 doctoral degrees. Our graduates are placed in top-tier research universities and pharmaceutical companies across the United States and Europe. Our faculty have been successful in securing tens of millions of dollars from private and federal agencies including the National Institutes of Health, the National Science Foundation, and the Department of Defense.

Now also located in the South Texas Research Facility (STRF), we offer a research-oriented, interdisciplinary program of study in the areas of cancer and aging and their prevention. Specific areas of study include: cell (and hormone) signaling, gene expression, epigenetics, cell cycle and checkpoint controls, DNA damage repair and associated stress responses, and regulated protein turnover. Under new leadership, Dr. Tim Huang is expanding our research to include a Systems approach to molecular medicine that offers students an integrated training program spanning molecular and cellular biology, quantitative biology, computational biology, and genomics.

Our goal is to educate and train the next generation of graduate students who will change the face of biomedical research and invent new ways to treat and prevent human diseases.

[More info...]

See the original post:
Molecular Medicine - Graduate School of Biomedical ...

Molecular medicine is a broad field, where physical, chemical, biological and medical techniques are used to describe molecular structures and mechanisms, identify fundamental molecular and genetic errors of disease, and to develop molecular interventions to correct them. The molecular medicine perspective emphasizes cellular and molecular phenomena and interventions rather than the previous conceptual and observational focus on patients and their organs.[1]

In November 1949, with the seminal paper, "Sickle Cell Anemia, a Molecular Disease",[2] in Science magazine, Linus Pauling, Harvey Itano and their collaborators laid the groundwork for establishing the field of molecular medicine.[3] In 1956, Roger J. Williams wrote Biochemical Individuality,[4] a prescient book about genetics, prevention and treatment of disease on a molecular basis, and nutrition which is now variously referred to as individualized medicine[5] and orthomolecular medicine.[6] Another paper in Science by Pauling in 1968,[7] introduced and defined this view of molecular medicine that focuses on natural and nutritional substances used for treatment and prevention.

Published research and progress was slow until the 1970s' "biological revolution" that introduced many new techniques and commercial applications.[8]

Molecular medicine is a new scientific discipline in European universities. Combining contemporary medical studies with the field of biochemistry, it offers a bridge between the two subjects. At present only a handful of universities offer the course to undergraduates. With a degree in this discipline the graduate is able to pursue a career in medical sciences, scientific research, laboratory work and postgraduate medical degrees.

Core subjects are similar to biochemistry courses and typically include gene expression, research methods, proteins, cancer research, immunology, biotechnology and many more besides. In some universities molecular medicine is combined with another discipline such as chemistry, functioning as an additional study to enrich the undergraduate program.

Go here to see the original:
Molecular medicine - Wikipedia, the free encyclopedia

Recent Molecular Medicine Publications

Bowman NM, Juliano JJ, Snider CJ, Kharabora O, Meshnick SR, Vulule J, John CC, Moormann AM. Am J Trop Med Hyg. 2016 Aug 1. pii: 15-0710. [Epub ahead of print]. PMID: 27481054. (Paper)

Shin J, Salameh JS, Richter JD. Sci Rep. 2016 Jul 6;6:29395. doi: 10.1038/srep29395. PMID: 27381259. (Paper)

Tanriverdi K, Kucukural A, Mikhalev E, Tanriverdi SE, Lee R, Ambros VR, Freedman JE. Anal Biochem. 2016 May 15;501:66-74. doi: 10.1016/j.ab.2016.02.019. Epub 2016 Mar 10. PMID:26969789 [PubMed - in process]. (Paper)

Smulan LJ, Ding W, Freinkman E, Gujja S, Edwards Y J.K., Walker, AK. Cell Rep. 2016 May 16. doi.org/10.1016/j.celrep.2016.05.086. In press. (Paper)

Lee PL, Tang Y, Li H, Guertin DA. Mol Metab. 2016 Apr 11;5(6):422-32. doi: 10.1016/j.molmet.2016.04.001. eCollection 2016 Jun. PMID: 27257602. (Paper)

Vertii A, Ivshina M, Zimmerman W, Hehnly H, Kant S, Doxsey S. Dev Cell. 2016 May 23;37(4):377-86. doi: 10.1016/j.devcel.2016.04.023. PMID: 27219065. (Paper)

Roth Flach RJ, Danai LV, DiStefano MT, Kelly M, Garcia Menendez L, Jurczyk A, Sharma RB, Jung DY, Kim JH, Kim JK, Bortell R, Alonso LC, Czech MP. J Biol Chem. 2016 May 20. pii: jbc.M116.718932. [Epub ahead of print]. PMID: 2722. (Paper)

Watanabe S,Tan D,Lakshminarasimhan M,Washburn MP,Hong EJ,Walz T,Peterson CL. Nat Commun.2015 May 12;6:7108. doi: 10.1038/ncomms8108. PMID: 25964121 [PubMed - indexed for MEDLINE] PMCID:PMC4431590. (Paper)

McManus M, Mick E, Hudson R, Mofenson LM, Sullivan JL, Somasundaran M, Luzuriaga K; PACTG 356 Investigators. PLoS One. 2016 Apr 22;11(4):e0154391. doi: 10.1371/journal.pone.0154391. eCollection 2016. PMID: 27104621 [PubMed - as supplied by publisher]. (Paper)

Tang Y, Wallace M, Sanchez-Gurmaches J, Hsiao WY, Li H, Lee PL, Vernia S, Metallo CM, Guertin DA. Nat Commun. 2016 Apr 21;7:11365. doi: 10.1038/ncomms11365.PMID: 27098609 [PubMed - in process]. (Paper)

Roth Flach RJ, Guo CA, Danai LV, Yawe JC, Gujja S, Edwards YJ, Czech MP. Mol Cell Biol. 2016 Apr 4. pii: MCB.01121-15. [Epub ahead of print]. PMID: 27044870 [PubMed - as supplied by publisher] (Paper)

Han MS, Barrett T, Brehm MA, Davis RJ. Cell Rep. 2016 Mar 24. pii: S2211-1247(16)30249-2. doi: 10.1016/j.celrep.2016.03.008. [Epub ahead of print]. PMID: 27052181 [PubMed - as supplied by publisher]. (Paper)

San Agustin JT, Klena N, Granath K, Panigrahy A, Stewart E, Devine W, Strittmatter L, Jonassen JA, Liu X, Lo CW, Pazour GJ. Nat Commun. 2016 Mar 22;7:11103. doi: 10.1038/ncomms11103. PMID: 27002738. PMCID:PMC4804176 (Paper)

Hung HF, Hehnly H, Doxsey S. Curr Biol. 2016 Mar 2. pii: S0960-9822(16)00075-0. doi: 10.1016/j.cub.2016.01.025. [Epub ahead of print]. PMID: 26948879 [PubMed - as supplied by publisher] (Paper)

Vernia S, Cavanagh-Kyros J, Barrett T, Tournier C, Davis RJ. Cell Rep. 2016 Mar 2. pii: S2211-1247(16)30129-2. doi: 10.1016/j.celrep.2016.02.026. [Epub ahead of print]. PMID: 26947074 [PubMed - as supplied by publisher]. (Paper)

Tang W, Tu S, Lee HC, Weng Z, Mello CC. Cell. 2016 Feb 25;164(5):974-84. doi: 10.1016/j.cell.2016.02.008. PMID: 26919432 [PubMed - in process] (Paper)

More

Continued here:
Program in Molecular Medicine - UMass Medical School ...